ACR Appropriateness Criteria® Induction and Adjuvant Therapy for N2 Non–small-cell Lung Cancer-Reference-Cited by-同舟云学术

ACR Appropriateness Criteria® Induction and Adjuvant Therapy for N2 Non–small-cell Lung Cancer

Published:2015-04 Issue:2 Volume:38 Page:197-205
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Willers Henning,Stinchcombe Thomas E.,Barriger R. Bryan,Chetty Indrin J.,Ginsburg Mark E.,Kestin Larry L.,Kumar Sanath,Loo Billy W.,Movsas Benjamin,Rimner Andreas,Rosenzweig Kenneth E.,Videtic Gregory M. M.,Chang Joe Yujiao

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference77 articles.

1. Revisions in the International System for Staging Lung Cancer.;Mountain;Chest,1997

2. Stage IIIA-N2 NSCLC: a review of its treatment approaches and future developments.;van Meerbeeck;Lung Cancer,2009

3. . Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications.;Andre;J Clin Oncol,2000

4. Multimodality therapy for stage IIIA (N2) lung cancer. An overview.;Ginsberg;Chest,1993

5. . Prognosis of unsuspected but completely resectable N2 non-small cell lung cancer.;van Klaveren;Ann Thorac Surg,1993

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and optimization various formulations of PEGylated niosomal nanoparticles loaded with phytochemical agents: potential anti-cancer effects against human lung cancer cells;Pharmacological Reports;2023-03-01

2. A Risk Model to Predict the Delivery of Adjuvant Chemotherapy Following Lung Resection in Patients With Pathologically Positive Lymph Nodes;Seminars in Thoracic and Cardiovascular Surgery;2022-03

3. ASSESSMENT AND COMPARISON OF QUALITY OF LIFE AND SYMPTOM RELIEF IN PATIENT OF INOPERABLE NON-METASTATIC NON SMALL CELL LUNG CANCER UNDERGOING DIFFERENT PALLIATIVE RADIATION THERAPY.;INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH;2020-11-01

4. Local treatment of stage IIIA-N2 nonsmall cell lung cancer: surgery and/or radiotherapy;Current Opinion in Oncology;2020-01

5. PACIFIC: Time for a surgical IIIA uprising;The Journal of Thoracic and Cardiovascular Surgery;2018-09